Measuring glycated proteins: clinical and methodological aspects.

Diabetes technology & therapeutics

Volumn 1, Issue 1, 1999, Pages 57-70

  Cohen, M P ^a   Clements, R S ^a  

^a The Science Center Philadelphia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; FRUCTOSAMINE; GLYCOSYLATED SERUM ALBUMIN; PLASMA PROTEIN; SERUM ALBUMIN;

ANIMAL; BLOOD; DIABETES MELLITUS; GLYCOSYLATION; HUMAN; METABOLISM; PROTEIN PROCESSING; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FRUCTOSAMINE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SERUM ALBUMIN;

EID: 0033086268     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091599317585     Document Type: Review

References (133)